SEC Company Response from ORAGENICS INC (OGEN) (CIK 0001174940) (OGEN) — Jan 9, 2020
ORAGENICS INC (OGEN) (CIK 0001174940)
Date: Jan. 9, 2020 · CIK: 0001174940 · Accession: 0001493152-20-000401
AI Filing Summary & Sentiment
File numbers found in text: 333-235763
Show Raw Text
CORRESP
1
filename1.htm
Oragenics,
Inc.
4902
Eisenhower Boulevard, Suite
Tampa,
Florida 33634
January
9, 2020
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
D.C. 20549
Attn:
Mr. Paul Fischer
Re:
Oragenics,
Inc. (the “Company”)
Registration
Statement on Form S-3
File
No. 333-235763
Request
for Acceleration
Dear
Ladies and Gentlemen:
In
accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”)
respectfully requests that the Securities and Exchange Commission take appropriate action to cause the above referenced Registration
Statement on Form S-3 (the “Registration Statement”) to be declared effective at 4:00 p.m., Eastern Time, on
Monday, January 13, 2020, or as soon thereafter as is practicable.
Once
the Registration Statement has been declared effective, please orally confirm that event with Mark Catchur of Shumaker, Loop & Kendrick, LLP at (813) 227-2264. Thank you for your assistance in this matter.
Very
truly yours,
By:
/s/
Michael Sullivan
Name:
Michael Sullivan
Title:
Chief
Financial Officer
cc:
Mark A. Catchur, Shumaker, Loop & Kendrick, LLP